Barbara Muz
Overview
Explore the profile of Barbara Muz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1750
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sun J, Corradini S, Azab F, Shokeen M, Muz B, Miari K, et al.
Leukemia
. 2024 Aug;
38(11):2355-2365.
PMID: 39215060
Multiple myeloma (MM) is the cancer of plasma cells within the bone marrow and remains incurable. Tumor-associated macrophages (TAMs) within the tumor microenvironment often display a pro-tumor phenotype and correlate...
2.
Maksimos M, Muz B, Magnani J, Azab A
Blood Cancer J
. 2023 Apr;
13(1):48.
PMID: 37029121
No abstract available.
3.
Massalska M, Ciechomska M, Kuca-Warnawin E, Burakowski T, Kornatka A, Radzikowska A, et al.
J Inflamm Res
. 2022 Dec;
15:6813-6829.
PMID: 36578517
Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease with systemic inflammation finally resulting in damaged joints. One of the RA development models suggests bone marrow (BM) as a place...
4.
Darawshi O, Muz B, Naamat S, Praveen B, Mahameed M, Goldberg K, et al.
Cell Death Dis
. 2022 Nov;
13(11):969.
PMID: 36400754
Multiple myeloma (MM) causes approximately 20% of deaths from blood cancers. Notwithstanding significant therapeutic progress, such as with proteasome inhibitors (PIs), MM remains incurable due to the development of resistance....
5.
Weisberg E, Chowdhury B, Meng C, Case A, Ni W, Garg S, et al.
Blood Cancer J
. 2022 Jul;
12(7):110.
PMID: 35853853
Bromodomain-containing protein 9 (BRD9), an essential component of the SWI/SNF chromatin remodeling complex termed ncBAF, has been established as a therapeutic target in a subset of sarcomas and leukemias. Here,...
6.
Sun J, Park C, Guenthner N, Gurley S, Zhang L, Lubben B, et al.
J Immunother Cancer
. 2022 Apr;
10(4).
PMID: 35428704
Multiple myeloma (MM) is a cancer of plasma cells in the bone marrow (BM) and represents the second most common hematological malignancy in the world. The MM tumor microenvironment (TME)...
7.
Muz B, Azab A, Confalonieri L, Del Grosso E, Fallarini S, Imperio D, et al.
Bioorg Med Chem
. 2022 Feb;
59:116659.
PMID: 35217358
The synthesis of d-glucoheptose derivative containing a boronic moiety is described herein. Starting from benzyl 6,7-dideoxy-2,3,4-tri-O-benzyl-β-d-gluco-ept-6-enopyranoside, the introduction of the boronic acid was performed through a metathesis reaction by using...
8.
Alhallak K, Sun J, Muz B, Jeske A, ONeal J, Ritchey J, et al.
J Cell Mol Med
. 2022 Jan;
26(3):940-944.
PMID: 35014164
Immunotherapy is an attractive approach for treating cancer. T-cell engagers (TCEs) are a type of immunotherapy that are highly efficacious; however, they are challenged by weak T-cell activation and short...
9.
Alhallak K, Jeske A, de la Puente P, Sun J, Fiala M, Azab F, et al.
Sci Rep
. 2021 Sep;
11(1):19343.
PMID: 34588522
Cancer patients undergo detrimental toxicities and ineffective treatments especially in the relapsed setting, due to failed treatment attempts. The development of a tool that predicts the clinical response of individual...
10.
Sun J, Chen Y, Lubben B, Adebayo O, Muz B, Azab A
Leuk Res Rep
. 2021 Sep;
16:100268.
PMID: 34584838
CD47 is a surface glycoprotein expressed by host cells to impede phagocytosis upon binding to macrophage SIRPα, thereby represents an immune checkpoint known as the "don't-eat-me" signal. However, accumulating evidence...